Moxonidine 0.2 MG
REG 15-021
Approved small_molecule completed
Quick answer
Moxonidine 0.2 MG for Central Sympathetic Nervous System Diseases is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Central Sympathetic Nervous System Diseases
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed